Evidence map›Paper›PMID 25266476›Full record

ArticleThe EMBO journal2014

Splicing together sister chromatids.

Juan Valcárcel, Marcos Malumbres

Abstract readComment
In one paragraph

Article in The EMBO journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Isolation of mutant alleles of the U6 snRNA mmicroPublication biology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Juan ValcárcelCentre de Regulació Genòmica, Universitat Pompeu Fabra Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
Marcos MalumbresCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Splicing of pre‐mRNAs is a necessary step for expression of the majority of genes in higher eukaryotes, and its regulation through alternative splice site selection shapes their proteomes. Defects in multiple splicing factors result in aberrant mitotic progression, although the molecular basis for this observation has remained elusive. Recent papers in The EMBO Journal and EMBO Reports reveal that expression of sororin, a critical regulator that stabilizes cohesin rings in sister chromatids, is exquisitely sensitive to defects in the splicing machinery, thus explaining the striking link between spliceosome function and chromosome segregation.

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellMutationNeoplasm ProteinsPhosphoproteinsRibonucleoprotein, U2 Small NuclearRNA, NeoplasmSister Chromatid ExchangeAdaptor Proteins, Signal TransducingCell Cycle ProteinsChromatidsCytoskeletal ProteinsHumansNuclear Receptor CoactivatorsRNA PrecursorsRNA SplicingRNA Splicing FactorsAdaptor Proteins, Signal TransducingAPC2 protein, humanCDCA5 protein, humanCell Cycle ProteinsCytoskeletal ProteinsNeoplasm ProteinsNuclear Receptor CoactivatorsPhosphoproteinsRibonucleoprotein, U2 Small NuclearRNA, NeoplasmRNA PrecursorsRNA Splicing FactorsSF3B1 protein, humanSNW1 protein, human

Identifiers

PMID25266476
PMCPMC4282569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.